SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Shanghai Cancer Report 2008 [in Chinese]. Shanghai, China: Shanghai Municipal Center of Disease Control and Prevention; 2008.
  • 2
    Simunovic M, Sexton R, Rempel E, Moran BJ, Heald RJ. Optimal preoperative assessment and surgery for rectal cancer may greatly limit the need for radiotherapy. Br J Surg. 2003; 90: 999-1003.
  • 3
    Willett CG, Badizadegan K, Ancukiewicz M, Shellito PC. Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum. 1999; 42: 167-173.
  • 4
    Gunderson LL, Sargent DJ, Tepper JE, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol. 2004; 22: 1785-196.
  • 5
    Lombardi R, Cuicchi D, Pinto C, et al. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment? Ann Surg Oncol. 2010; 17: 838-845.
  • 6
    Batsakis JG. Nerves and neurotropic carcinomas. Ann Otol Rhinol Laryngol. 1985; 94(Pt 1): 426-427.
  • 7
    Veness MJ. Perineural spread in head and neck skin cancer. Australas J Dermatol. 2000; 41: 117-119.
  • 8
    Rubin MA, Mucci NR, Manley S, et al. Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively? J Urol. 2001; 165: 114-118.
  • 9
    Beard CJ, Chen MH, Cote K, et al. Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer. Int J Radiat Oncol Biol Phys. 2004; 58: 19-24.
  • 10
    Fagan JJ, Collins B, Barnes L, D'Amico F, Myers EN, Johnson JT. Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1998; 124: 637-640.
  • 11
    Fujita S, Nakanisi Y, Taniguchi H, et al. Cancer invasion to Auerbach's plexus is an important prognostic factor in patients with pT3-pT4 colorectal cancer. Dis Colon Rectum. 2007; 50: 1860-1866.
  • 12
    Di Fabio F, Nascimbeni R, Villanacci V, et al. Prognostic variables for cancer-related survival in node-negative colorectal carcinomas. Dig Surg. 2004; 21: 128-133.
  • 13
    Burdy G, Panis Y, Alves A, Nemeth J, Lavergne-Slove A, Valleur P. Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence. Dis Colon Rectum. 2001; 44: 1682-1688.
  • 14
    Liebig C, Ayala G, Wilks J, et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol. 2009; 27: 5131-5137.
  • 15
    Guillem JG, Diaz-Gonzalez JA, Minsky BD, et al. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol. 2008; 26: 368-373.
  • 16
    Park IJ, Kim HC, Yu CS, Kim TW, Jang SJ, Kim JC. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer. Ann Surg Oncol. 2008; 15: 519-525.
  • 17
    Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001; 345: 638-646.
  • 18
    Steel MC, Woods R, Mackay JM, Chen F. Extent of mesorectal invasion is a prognostic indicator in T3 rectal carcinoma. ANZ J Surg. 2002; 72: 483-487.
  • 19
    Nissan A, Stojadinovic A, Shia J, et al. Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol. 2006; 24: 4078-4084.
  • 20
    Picon AI, Moore HG, Sternberg SS, et al. Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. Int J Colorectal Dis. 2003; 18: 487-492.
  • 21
    Neumann E. Secondare cancroid infiltration des nervus mentalis bei einem. Arch Pathol Anat. 1862; 24: 201.
  • 22
    Ozaki H, Hiraoka T, Mizumoto R, et al. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today. 1999; 29: 16-22.
  • 23
    Law WL, Chu KW. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg. 2004; 240: 260-268.
  • 24
    Duraker N, Sisman S, Can G. The significance of perineural invasion as a prognostic factor in patients with gastric carcinoma. Surg Today. 2003; 33: 95-100.
  • 25
    Huh JW, Kim HR, Kim YJ. Prognostic value of perineural invasion in patients with stage II colorectal cancer. Ann Surg Oncol. 2010; 17: 2066-2072.
  • 26
    Tsai HL, Chu KS, Huang YH, et al. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection. J Surg Oncol. 2009; 100: 736-743.
  • 27
    Tianhang L, Guoen F, Jianwei B, Liye M. The effect of perineural invasion on overall survival in patients with gastric carcinoma. J Gastrointest Surg. 2008; 12: 1263-1267.
  • 28
    Bockman DE, Buchler M, Beger HG. Interaction of pancreatic ductal carcinoma with nerves leads to nerve damage. Gastroenterology. 1994; 107: 219-230.
  • 29
    Nagakawa T, Kayahara M, Ohta T, Ueno K, Konishi I, Miyazaki I. Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer. Int J Pancreatol. 1991; 10: 113-119.
  • 30
    Horn A, Dahl O, Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum. 1991; 34: 798-804.
  • 31
    Matsushima T, Mori M, Kido A, Adachi Y, Sugimachi K. Preoperative estimation of neural invasion in rectal carcinoma. Oncol Rep. 1998; 5: 73-76.
  • 32
    Peng J, Lu JJ, Zhu J, et al. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer. Cancer J. 2008; 14: 54-61.
  • 33
    Pour PM, Bell RH, Batra SK. Neural invasion in the staging of pancreatic cancer. Pancreas. 2003; 26: 322-325.
  • 34
    Kurtz KA, Hoffman HT, Zimmerman MB, Robinson RA. Perineural and vascular invasion in oral cavity squamous carcinoma: increased incidence on re-review of slides and by using immunohistochemical enhancement. Arch Pathol Lab Med. 2005; 129: 354-359.
  • 35
    Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000; 124: 979-994.
  • 36
    Compton CC. Pathology report in colon cancer: what is prognostically important? Dig Dis. 1999; 17: 67-79.
  • 37
    Shirouzu K, Isomoto H, Kakegawa T. Prognostic evaluation of perineural invasion in rectal cancer. Am J Surg. 1993; 165: 233-237.
  • 38
    Bentzen SM, Balslev I, Pedersen M, et al. Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis. Br J Cancer. 1992; 65: 102-107.
  • 39
    Miknyoczki SJ, Lang D, Huang L, Klein-Szanto AJ, Dionne CA, Ruggeri BA. Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior. Int J Cancer. 1999; 81: 417-427.
  • 40
    Djakiew D, Pflug BR, Delsite R, et al. Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein. Cancer Res. 1993; 53: 1416-1420.